158 related articles for article (PubMed ID: 14554007)
1. Promoting proteasomes: trash to treasure.
Sussman HE
Drug Discov Today; 2003 Oct; 8(19):866-8. PubMed ID: 14554007
[No Abstract] [Full Text] [Related]
2. Molecule of the month. Bortezomib.
Drug News Perspect; 2003 Jun; 16(5):324. PubMed ID: 12942163
[No Abstract] [Full Text] [Related]
3. Proteasome inhibition: a novel approach to cancer therapy.
Adams J
Trends Mol Med; 2002; 8(4 Suppl):S49-54. PubMed ID: 11927288
[TBL] [Abstract][Full Text] [Related]
4. Human somatic cell knockouts reveal determinants of sensitivity and resistance to proteasome inhibitor PS-341.
Lee C; Waldman T
Cancer Biol Ther; 2003; 2(6):700-1. PubMed ID: 14688480
[No Abstract] [Full Text] [Related]
5. Potential for proteasome inhibition in the treatment of cancer.
Adams J
Drug Discov Today; 2003 Apr; 8(7):307-15. PubMed ID: 12654543
[TBL] [Abstract][Full Text] [Related]
6. Cancer research. Taking garbage in, tossing cancer out?
Garber K
Science; 2002 Jan; 295(5555):612-3. PubMed ID: 11809952
[No Abstract] [Full Text] [Related]
7. Proteasome inhibitors as new anticancer drugs.
Adams J
Curr Opin Oncol; 2002 Nov; 14(6):628-34. PubMed ID: 12409653
[TBL] [Abstract][Full Text] [Related]
8. Molecular pathways that modify tumor radiation response.
Pervan M; Pajonk F; Sun JR; Withers HR; McBride WH
Am J Clin Oncol; 2001 Oct; 24(5):481-5. PubMed ID: 11586100
[TBL] [Abstract][Full Text] [Related]
9. [Proteasome inhibitor, bortezomib (Vercade), potently inhibits the growth of adult T-cell leukemia cells].
Satou Y; Matsuoka M
Nihon Rinsho; 2004 Jul; 62(7):1363-7. PubMed ID: 15283157
[TBL] [Abstract][Full Text] [Related]
10. A review of the proteasome inhibitor bortezomib in multiple myeloma.
Richardson PG
Expert Opin Pharmacother; 2004 Jun; 5(6):1321-31. PubMed ID: 15163277
[TBL] [Abstract][Full Text] [Related]
11. First proteasome inhibitor approved for multiple myeloma.
Twombly R
J Natl Cancer Inst; 2003 Jun; 95(12):845. PubMed ID: 12813164
[No Abstract] [Full Text] [Related]
12. Differential effects of the proteasome inhibitor bortezomib on apoptosis and angiogenesis in human prostate tumor xenografts.
Williams S; Pettaway C; Song R; Papandreou C; Logothetis C; McConkey DJ
Mol Cancer Ther; 2003 Sep; 2(9):835-43. PubMed ID: 14555702
[TBL] [Abstract][Full Text] [Related]
13. The proteasome: a suitable antineoplastic target.
Adams J
Nat Rev Cancer; 2004 May; 4(5):349-60. PubMed ID: 15122206
[No Abstract] [Full Text] [Related]
14. Bortezomib: understanding the mechanism of action.
Piperdi B; Ling YH; Liebes L; Muggia F; Perez-Soler R
Mol Cancer Ther; 2011 Nov; 10(11):2029-30. PubMed ID: 22072812
[No Abstract] [Full Text] [Related]
15. Phase I trial of the proteasome inhibitor bortezomib in patients with advanced solid tumors with observations in androgen-independent prostate cancer.
Papandreou CN; Daliani DD; Nix D; Yang H; Madden T; Wang X; Pien CS; Millikan RE; Tu SM; Pagliaro L; Kim J; Adams J; Elliott P; Esseltine D; Petrusich A; Dieringer P; Perez C; Logothetis CJ
J Clin Oncol; 2004 Jun; 22(11):2108-21. PubMed ID: 15169797
[TBL] [Abstract][Full Text] [Related]
16. Clinical update: proteasome inhibitors in solid tumors.
Lenz HJ
Cancer Treat Rev; 2003 May; 29 Suppl 1():41-8. PubMed ID: 12738242
[TBL] [Abstract][Full Text] [Related]
17. Development of the proteasome inhibitor Velcade (Bortezomib).
Adams J; Kauffman M
Cancer Invest; 2004; 22(2):304-11. PubMed ID: 15199612
[TBL] [Abstract][Full Text] [Related]
18. [Proteasome inhibitors].
Hatake K; Mishima Y; Terui Y
Gan To Kagaku Ryoho; 2004 Jul; 31(7):999-1002. PubMed ID: 15272575
[TBL] [Abstract][Full Text] [Related]
19. The role of proteasome inhibitors in solid tumors.
Park DJ; Lenz HJ
Ann Med; 2004; 36(4):296-303. PubMed ID: 15224656
[TBL] [Abstract][Full Text] [Related]
20. PS-341, a novel proteasome inhibitor, induces Bcl-2 phosphorylation and cleavage in association with G2-M phase arrest and apoptosis.
Ling YH; Liebes L; Ng B; Buckley M; Elliott PJ; Adams J; Jiang JD; Muggia FM; Perez-Soler R
Mol Cancer Ther; 2002 Aug; 1(10):841-9. PubMed ID: 12492117
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
